| To view this email as a web page, click here. | |
 |
|
| We noticed it’s been a while since you last opened an email from us! We gathered some of our more recent and popular lung cancer content that your peers have viewed. We hope this content is beneficial and helps improve the treatment options you provide your patients. | |
| Podcast Listen to Dr. Oxnard on Opening the Door for Precision Medicine in Lung Cancer |
|
| Attend a complimentary virtual event Institutional Perspectives in Cancer (IPC) Frontline treatment of NSCLC |
|
| Rapid Readouts Learn about the updated data from the phase 1/2 KRYSTAL-1 trial for KRASG12C mutant NSCLC |
|
| We want to ensure you continue to receive interesting and relevant content. Please take a moment to choose the types of communications you’d like to receive in our email preference center. |
|
 |
|
 |
|